Koninklijke Philips N.V. (PHG)
| Market Cap | 24.88B |
| Revenue (ttm) | 20.19B |
| Net Income (ttm) | -517.78M |
| Shares Out | 906.40M |
| EPS (ttm) | -0.55 |
| PE Ratio | n/a |
| Forward PE | 12.89 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,114,456 |
| Open | 27.30 |
| Previous Close | 26.96 |
| Day's Range | 27.25 - 27.47 |
| 52-Week Range | 17.75 - 29.44 |
| Beta | 0.70 |
| Analysts | Hold |
| Price Target | n/a |
| Earnings Date | Apr 29, 2024 |
About PHG
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focus... [Read more]
Financial Performance
In 2023, PHG's revenue was 18.17 billion, an increase of 1.92% compared to the previous year's 17.83 billion. Losses were -466.00 million, -71.02% less than in 2022.
Financial numbers in EUR Financial StatementsNews
Philips announces exchange ratio for 2023 dividend
May 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 exist...
Philips shareholders approve all proposals at the AGM 2024
May 7, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, in...
Philips Avent Supports March of Dimes' It Starts With Mom Initiative to Help New Moms Access Resources to Prioritize their Health and Well-being
Philips Avent introduced Share the Care brand positioning in March 2024 , encouraging families, friends and communities to better support moms so they can prioritize their well-being and self-care. CA...
Philips CPAP Settlement: What to Know
Philips agreed to a $1.1 billion settlement over CPAP and ventilator machines.
Nicklaus Children's Health System, Philips to provide innovative patient and staff experience, helping to enhance outcomes for the smallest of patients
April 30, 2024 Philips AI-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence Amsterda...
Philips stock soars on $1.1 billion respiratory device settlement
Koninklijke Philips (PHG) reached a $1.1 billion settlement over a US device recall for its respiratory ventilator devices, causing shares of the company to jump on Monday. The payment was originally ...
Philips CEO on $1.1 billion settlement over DreamStation sleep apnea machines
Roy Jakobs, Philips CEO, joins 'Money Movers' to discuss the company's recent settlement, the sales of the company's sleep apnea machines, and more.
Philips Stock Soars as Company Reaches $1.1B Settlement in US for Sleep Apnea Devices
Koninklijke Philips (PHG) shares traded in the U.S. soared nearly 30% Monday morning after the Dutch medical devices giant agreed to a $1.1 billion settlement to pay out personal injury cases in the U...
Philips pays $1.1B to settle sleep apnea device suits
Philips Respironics announced that it agreed to pay over a billion dollars to settle claims stemming from the 2021 U.S. recall of its sleep therapy devices.
'Vast majority' of legal cases over apnea recall now settled: Philips CEO
Philips CEO Roy Jakobs comments on the company's first-quarter results and its agreement of a $1.1 billion settlement for personal injury and medical monitoring claims linked to the recall of some res...
Philips shares soar 30% after U.S. litigation settlement far lower than feared
Shares of Royal Philips NV soared on Monday, after the Dutch health-technology group announced a much lower-than-expected U.S. settlement over its Respironics ventilators.
Philips shares rocket 33% as firm settles U.S. respiratory device case
Philips shares soared Monday after the company agreed a $1.1 billion settlement in a U.S. case linked to the recall of some of its sleep apnea devices.
Philips $1.1B Sleep Apnea Settlement Covers All US Claims, CEO Says
Philips CEO Roy Jakobs discusses the firm's €982 million ($1.1 billion) provision to help settle US claims linked to a recall of sleep apnea medical devices, much lower than analysts expected. The Dut...
Philips agrees to $1.1 billion settlement over U.S. ventilator recall
Dutch medical devices maker Philips announced on Monday that it has agreed to a $1.1 billion settlement regarding personal injury lawsuits in the United States. This agreement relates to the global re...
Philips Settles U.S. Ventilator Claims
Philips has reached a $1 billion settlement in the U.S. related its Respironics ventilators, and backed its full-year guidance.
Philips pays $1.1 bln in U.S. settlement over ventilator recall
Dutch medical devices maker Philips said on Monday it had agreed to pay $1.1 billion in a settlement of personal injury cases in the United States related to the global recall of ventilators used to t...
Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4% Comparable order intake -3.8%, mainly due to China USD 1.1 billion Respironics lit...
Philips announces terms of US government deal on sleep apnea machines
Philips announced the main terms of an agreement it reached in January with the U.S. government on its new sleep apnea machines, sending shares in the Dutch health technology firm up almost 3% on Wedn...
Philips shares climb after finalizing pact with U.S. over device sales
Philips reiterated its financial outlook on Wednesday after finalizing a consent degree with the U.S. Department of Justice and Food and Drug Administration that will prevent it from selling new respi...
Philips Reaches Final Pact With U.S. Govt. on Ventilator Recall
Philips said it reached a final agreement with the U.S. Justice Department and Food and Drug Administration on terms of a settlement related its Respironics ventilators, and backed its medium-term gui...
Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward
April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips' subsidiaries Philips Holding USA and Philips Respir...
US federal court orders to restrict production of Philips' sleep apnea devices
A U.S. federal court issued a decree to restrict the production and sale of Philips' new sleep apnea machines at several facilities in the country, the Food and Drug Administration said on Tuesday.
Philips Foundation and March of Dimes partner to improve prenatal care access in underserved communities, helping address US maternal and infant health challenges
April 4, 2024 Mom & Baby Mobile Health Centers offering ultrasound screenings to expectant moms in Phoenix, Tucson, and Washington, DC
Philips Norelco Taps Actor Adam Scott for New Campaign
Campaign encourages shavers and groomers to embrace personal growth and shape their true selves with Philips Norelco CAMBRIDGE, Mass. , April 2, 2024 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: ...
Philips convenes the Annual General Meeting of Shareholders 2024
March 22, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with ex...